Learn About Peripheral Arterial Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Peripheral Arterial Disease on CME Webcast. On this on-line program, we are going to update you about new developments in peripheral artery disease. I’m pleased to introduce our guests. Dr. Michael Go is an Associate Professor of Surgery from the Division of Vascular Surgery here at Ohio State. And Dr. Said Atway is an Assistant Professor of Orthopedics from the Division of Podiatry.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review the anatomy and pathophysiology of PAD; and Review the demographics and diagnosis of PAD.

You’ll also learn about the following:

  • Limb preservation programs
  • Presenting signs and symptoms of foot ischemia
  • Tests used in evaluation of suspected peripheral arterial disease
  • Hyperbaric oxygen

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Education Covers Common Fractures

OSUWexnerbloglogo2014 On-line CME Education Covers Common Fractures. Bone fractures are still common but orthopedic surgeons have many more techniques that they can use to manage fractures in order to return patients back to normal function as rapidly as possible. Joining our moderator in the studio to update us on the management of common fractures is orthopedic trauma surgeon and Assistant Professor of Orthopedic Surgery from the Ohio State University, Dr. Ryan Harrison.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY common fractures; and DISCUSS treatment strategies for common fractures and expected outcomes.

You’ll also learn about the following:

  • Most common fractures seen in the ER
  • Initial management of suspected on-the-field athletic fractures
  • Cast techniques
  • Care of the cast
  • Splinting versus casting
  • Who needs to be admitted
  • Hip fracture and mortality
  • Timing of hip fracture surgery
  • Management of open fracture versus closed fracture
  • Reasons for delayed healing
  • Strength of a healed fracture
  • Rib fractures

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Melanoma Webcast Teaches Physicians On-line

OSUWexnerbloglogo2014 Melanoma Webcast Teaches Physicians On-line. This year in the United States, there will be 87,000 new cases of melanoma and nearly 10,000 Americans will die from it. In the past 40 years, the incidence of melanoma has increased 15 times. But the good news is that 5-year survival of melanoma has been slowly increasing over the past 40 years. On this CME webcast, we have two melanoma experts from the Ohio State University. First, to tell us about the diagnosis and surgical treatment of melanoma, surgical oncologist and Assistant Professor of Surgery, Dr. Alicia Terando. And then to update us on the treatment of advanced melanoma, medical oncologist and Associate Professor of Internal Medicine, Dr. Kari Kendra.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the current data on adjuvant therapies for melanoma; DISCUSS the therapies available for systemic treatment of melanoma; UNDERSTAND the risk factors and diagnosis of malignant melanoma; and UNDERSTAND the surgical and medical management modalities for localized, regional and metastatic melanoma.

You’ll also learn about the following:

  • Risk factors for melanoma
  • New treatments for melanoma
  • Punch biopsies for suspected melanoma
  • Surgery for metastases

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Acute and Chronic Myeloid Leukemia

OSUWexnerbloglogo2014CME Webcast Discusses Acute and Chronic Myeloid Leukemia. Joining our webcast to tell you all about the newest developments in chronic myelogenous leukemia is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Katherine Walsh. And then to tell you about acute myeloid leukemia is OSU hematologist and also Assistant Professor of Internal Medicine, Dr. Alice Mims.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the clinical presentation and diagnosis of CML; REVIEW the front line treatment options and milestones for response to treatment; DESCRIBE the clinical presentation and diagnosis of AML.

You’ll also learn about the following:

  • Presenting signs and symptoms of CML
  • Presenting signs and symptoms of AML
  • Stem cell transplant in CML
  • Initial evaluation and management of patients with suspected AML
  • Initial treatment of patients with AML
  • CML blast crisis
  • Leukemoid reaction versus CML
  • Which patients with AML require a lumbar puncture
  • Which patients with AML need a permanent venous catheter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.